Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. - Wikidata - wikimedia - TriplyDB

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

http://www.wikidata.org/entity/Q46966972

about

Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals In situ localization of P-glycoprotein (ABCB1) in human and rat brain Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes.Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation.Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier Drug resistance in brain diseases and the role of drug efflux transporters.Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells Neuropsychiatric complications of antiretroviral therapy.Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation.ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Immunological response as a source to variability in drug metabolism and transport.Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort.Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1.The Inhibitor Ko143 Is Not Specific for ABCG2 The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord.Role of drug efflux carriers in the healthy and diseased brain.The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects.Effects of delays in peripheral blood processing, including cryopreservation, on detection of CD31 expression on naive CD4 T cells.Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.Blood-brain barrier: structural components and function under physiologic and pathologic conditions.Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection.Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids.HIV and viral protein effects on the blood brain barrier.Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model.Neuronal PINCH is regulated by TNF-α and is required for neurite extension.Novel expression of PINCH in the central nervous system and its potential as a biomarker for human immunodeficiency virus-associated neurodegeneration.Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells.Large-scale N-glycoproteome map of rat brain tissue: simultaneous characterization of insoluble and soluble protein fractions.Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

P2860

Q28069383-DDB6FC56-E2E6-4E44-9AC8-71901328D438 Q33248008-826E3744-4055-4B94-A356-D79DE1CB0452 Q33351549-9361181B-88A5-45A5-856D-44CE87EEF1D9 Q33684254-ABCC2E4F-C70D-4F1D-8D6C-D8CEF942D876 Q33713071-9B21CADB-6856-4832-8A33-8F03A3E4C536 Q33900889-9C115C70-9A47-4798-B627-B63753CF8892 Q33988704-A69763BB-EFAB-4968-B682-D029988743FE Q34170914-49BCBAAB-EBC9-4DBD-A6F3-CDB09B399116 Q34565848-7C2C6F1D-1017-4865-997D-CB56F586DDBC Q34661343-95F760E6-088B-419A-8A75-B59593E8A789 Q34761828-DDCA1C49-24E7-4C3D-AD7E-5072B619E843 Q34958706-5C155B43-6753-4F5D-9BC7-6F7651FB00FA Q35132580-E43F972E-8EB5-4BAE-A508-0C63A42D56C8 Q35177355-FDF1C79B-425A-4F1A-BBCC-005984435AB9 Q35749503-0386AF73-D9BB-4CBF-9ABD-FE9EAD6BFB17 Q35827510-9AF5A7FC-7F49-499F-9DAC-EE4C7DFB3F68 Q35857191-2BE5079B-ED64-4057-AB34-224D6DCAFAFB Q35962045-4B777DB0-5295-4C4F-8877-8E68D3DE7533 Q36590671-72D6822C-1E14-4632-B161-31DF3852B033 Q36626922-4B4DB380-1986-4D3D-8B92-6FC812511272 Q36697929-702F6F5F-7523-47DB-A5D2-5294D75CF195 Q36746919-94EC1C5C-4E43-438F-8B18-1879044D1FD8 Q36772901-427CAEFA-2FB7-4879-9A53-4047524CAD6B Q37015412-ECB043D5-75B7-4B88-9802-A6CCA70C6B4F Q37105870-CC6D994D-412D-4978-B5DA-2118135DE314 Q37224797-0C04CDE4-41D2-4390-B17B-05D00651A68A Q37243920-B73E2023-3357-47F4-B908-ABAAD789EFBB Q37379470-73D03EB8-5A4B-4F20-966B-AE75877F1969 Q37575649-CA523E3B-0228-4466-B3A4-7044941E9C81 Q37875183-F92F837B-28D2-411D-B5B2-B4FB378A5999 Q38007464-47504584-D519-4FD3-9596-3E3AFE0F21EC Q38824376-D8BE4856-B7FA-497D-BB24-B83DDF77C1AE Q42243855-776FE41E-9B5F-4570-B857-F2A0BE9E9B45 Q42745285-90F29475-4205-4FBF-AE17-CA14EDC0E61E Q45395285-17A673CE-7A45-46AA-930C-B9A4D8D15CC3 Q47707801-C3ACB522-FECC-4DBE-BB2D-AF8DD41CD613 Q48871408-661076EA-2BB6-471D-AF54-C2DF8DD40D41 Q48912848-3D4CD211-DEBD-4D54-BE9D-8BD01F0A9AFC Q52689036-DD3E4D5B-9E3A-4DFE-86AE-72B88767EF38

P2860

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

http://www.wikidata.org/entity/Q46966972

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

@en

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

@nl

type

label

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

@en

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

@nl

prefLabel

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

@en

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

@nl

P1433

Q46966972-8E3377E6-4F87-45A3-AEA4-EB1EF9F678FB

P1476

Q46966972-183D648E-021A-4F06-B916-212C0540AA36

P2093

Q46966972-0C670217-A6B0-4E2B-AD62-47A4C6F95DAE

Q46966972-1992D4D7-A960-4818-B8B2-9C92829F985C

Q46966972-820127F6-D5E7-4096-9B3C-8547F1F34DF6

Q46966972-B7B049E2-1E03-41A0-B531-6AE083ADFCD2

Q46966972-C8140B27-539F-49EF-AEFC-D17F52097259

Q46966972-D56004AB-8177-4554-92FA-720203E5ADF8

P2860

Q46966972-0061DFEA-AB20-4979-88DA-6AEC0ADCB9A8

Q46966972-06FF8171-F564-4D05-AEB5-188CE86DA240

Q46966972-0904405A-2B47-4F02-9F02-8B1098861A05

Q46966972-1AD79DC5-6CBA-4B17-8C7E-4114C0787DFF

Q46966972-1C21D7E3-2E52-4CA5-A0DC-FB4F9311BE57

Q46966972-20B217F3-CB26-4EBB-95D3-77EE9DE9AFDF

Q46966972-2680EE6F-2F2A-4A43-80AB-028EA4F39523

Q46966972-29E11545-6DEC-4F57-A9AC-72F59EF040F4

Q46966972-39A55EBE-EA65-4BA9-BF61-E2A1A523BAF5

Q46966972-39C3F649-A9DE-4519-AFB8-BC1FCBDD5699

P304

Q46966972-5424ECE8-995D-4E06-A7F6-01CFFB3C0831

P31

Q46966972-47AF8015-10E4-4F58-BA13-3E42228BFBC3

P356

Q46966972-1B9D2C15-E2DC-4541-9D2E-6CC05D9EB7CC

P433

Q46966972-AE86110F-F585-48F1-8F52-FC2310E259A0

P478

Q46966972-0C278183-D9D7-4385-8273-DA942DF34941

P50

Q46966972-1DFD8916-0C0B-4FB1-8203-21F65BEC548E

P577

Q46966972-C1189C5C-C1F5-4639-9D26-B301F9F0FE02

P5875

Q46966972-680ABDA9-992E-43CD-8B79-99B6F62DBC7B

P698

Q46966972-525C5606-C668-4865-861C-9CD73DB61D4F

P356

P1433

Journal of Neuropathology & Experimental Neurology

P1476

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.

@en

P2093

Aline Grigorian

http://www.w3.org/2001/XMLSchema#string

Anthony Adame

http://www.w3.org/2001/XMLSchema#string

Dianne Langford

http://www.w3.org/2001/XMLSchema#string

Lawrence Hansen

http://www.w3.org/2001/XMLSchema#string

Ronald J Ellis

http://www.w3.org/2001/XMLSchema#string

Rosemary Hurford

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

Interactions between endothelial cells and HIV-1.

Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.

Neuropathology of human immunodeficiency virus infection.

P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection.

P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?

Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1.

The keys of oxidative stress in acquired immune deficiency syndrome apoptosis.

P304

1038-1047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/63.10.1038

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Eliezer Masliah

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8186056

http://www.w3.org/2001/XMLSchema#string

P698

15535131

http://www.w3.org/2001/XMLSchema#string